Inventor · disambiguated record
Dorin Toader
Also filed as: TOADER DORIN
10 granted patents·10 pending applications·17 citations·filing 2004–2025
83Inventor score
Top patents by PatentIndex Score
20 records- 0195US11155567B2Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·6 cites·14 claims
- 0292US12156870B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·1 cites·30 claims
- 0387US11939343B2Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2021·Granted Mar 26, 2024·1 cites·11 claims
- 0487US9427479B2Tubulysin derivativesMEDIMMUNE LLC·Filed 2015·Granted Aug 30, 2016·5 cites·41 claims
- 0584US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 0680US12440576B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 0780US2025352662A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0878US2025011339A1Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0972US2024148887A1Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1071US2024269306A1B7h4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1169US2022378749A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1267US11964024B2B7H4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·30 claims
- 1367US11786605B2Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·8 claims
- 1460US2023398229A1Antibody drug conjugates comprising sting agonists, combinations and methods of useMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1557US10159745B2Tubulysin derivativesMEDIMMUNE LLC·Filed 2016·Granted Dec 25, 2018·0 cites·18 claims
- 1654US2023021500A1Cysteine engineered antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1753US2023074558A1Dimeric compounds as sting agonistsMERSANA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1843US11414477B2Methods for preparing antibodies with a defined glycosylation patternMEDIMMUNE LLC·Filed 2017·Granted Aug 16, 2022·0 cites·13 claims
- 1942US2007149560A1Novel fused triazolones and the uses thereofASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2041US2009275570A1Substituted heterocycles and their use as chk1, pdk1 and pak inhibitorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dorin Toader files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →